Cargando…
MeCP2, a target of miR-638, facilitates gastric cancer cell proliferation through activation of the MEK1/2–ERK1/2 signaling pathway by upregulating GIT1
Methyl-CpG binding protein 2 (MeCP2) is involved in the carcinogenesis and progression of multiple types of cancer. However, its precise role in gastric cancer (GC) and the relevant molecular mechanism remain unknown. In the present study, we found that miR-638 levels were lower in GC tissues and GC...
Autores principales: | Zhao, L Y, Tong, D D, Xue, M, Ma, H L, Liu, S Y, Yang, J, Liu, Y X, Guo, B, Ni, L, Liu, L Y, Qin, Y N, Wang, L M, Zhao, X G, Huang, C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5541712/ https://www.ncbi.nlm.nih.gov/pubmed/28759023 http://dx.doi.org/10.1038/oncsis.2017.60 |
Ejemplares similares
-
MeCP2 SUMOylation rescues Mecp2-mutant-induced behavioural deficits in a mouse model of Rett syndrome
por: Tai, Derek J. C., et al.
Publicado: (2016) -
Genetic Modifiers of MeCP2 Function in Drosophila
por: Cukier, Holly N., et al.
Publicado: (2008) -
Genome Wide Distribution of Linker Histone H1.0 is Independent of MeCP2
por: Ito-Ishida, Aya, et al.
Publicado: (2018) -
Rett Syndrome and MECP2 Duplication Syndrome: Disorders of MeCP2 Dosage
por: Collins, Bridget E, et al.
Publicado: (2022) -
MeCP2_e2 partially compensates for lack of MeCP2_e1: A male case of Rett syndrome
por: Takeguchi, Ryo, et al.
Publicado: (2019)